J&J Said to Pay $2.2 Billion to End Risperdal Sales Probes

J&J Said to Pay $2.2 Billion to End Risperdal Sales Probes

Brent Lewin/Bloomberg

Johnson & Johnson became the latest company to end its membership in the American Legislative Exchange.